HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.
![handle is hein.gao/gaobadxtd0001 and id is 1 raw text is:
DOCUMENT RESUMHE
00521 - [A0590977]
Food ancl Drug Administration's iegulation of Food Additives.
January 13, 1977. 18 pp.
Testimcny before Sen. Gaylord Nelson, Chairaan, Senate Select
Committee on Small Business; by Gregory J. Ahart, Director,
Human Resources Div.
Issue Area: Consumer and Worker Protection: Standards, Laws, and
Regulatioas Enforcement (903).
Contact: Haman Resources Div.
Budget Function: Health: Prevention and Control ci Health
Problems (553).
Organization Concerned: Canadian Health Pro-ecticn Branch; Food
and Drug Administration; G. D. Searle and Co.; National
Academy of Sciences; National Institutes of Pealth: National
Cancer Inst.
Congressional Relevance: Senate Committef on the Judiciiry:
Administrative Practice and Procedure Subccomittee; Senate
Committee on Labor and Public Welfare: Health Subcommittee;
Senate Select Committee on Small Business.
Authority: Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301;
21 U.S.C. 348). 21 C.F.R. 121.1(k).
Reviews of color and food additives--Red No. 2,
saccharin and aspartame--included (1) the history of FDA's
reaulation, (2) the current status of testing, and (3) whether
the rev.ulatory artions taken complied with the aFpropriate act.
ed No. 2, the raze of dye generically known as amaranth which
s ets F))A composition and purity specifications, has tuen under
suspicicn for 15 years zs being possibly carcinogenic or toxic
to the rprodtjctive system Under existing law, action should
have L-cen taken I 1/' years after being placed on the
provisionil list, but extensions were granted. Red No. 2 was
finally oanned in January 1976. FDA limited saccharin use,
because of initial studies indicating possible adverse effects.
No final proof has been obtained. Aspartame, an artificial
sweetener, never was put on the market because of outside
objections to it and discovery of a possible carcinogen in its
makeup, but it did cause its manufacturer's testing procedures
to be questioned and found faulty. The initial regulation for
marketing aspartame haE been stayed, but final resolut4'on has
not been sade. Continued use of saccharin under the interi3 food
additive regulation should be justified, and, if justified,
should be used at the conventional level of 100 to i, rather
than the present 30 to 1, with the level of toluenesulfonamide
decreased. All agencies responsible for protecting the puhlic
from carcinoqens should cooperate to develop a uniform policy
for identifying and regulating carcinogenic chemicals and for
allowing public exposure to carcinogens. FDA should he required
to have all approved and proposed food additives tested for
carcinogenity. (SS)](ViewImageLocal?handle=hein.gao/gaobadxtd0001&div=1&collection=&method=preview&ext=.png&size=3)